Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011982
Filing Date
2024-08-13
Accepted
2024-08-13 08:00:36
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20240630x10q.htm   iXBRL 10-Q 1613406
2 EX-31.1 mrns-20240630xex31d1.htm EX-31.1 13392
3 EX-31.2 mrns-20240630xex31d2.htm EX-31.2 13520
4 EX-32.1 mrns-20240630xex32d1.htm EX-32.1 7711
5 GRAPHIC mrns-20240630x10q004.jpg GRAPHIC 14134
6 GRAPHIC mrns-20240630x10q007.jpg GRAPHIC 53183
  Complete submission text file 0001558370-24-011982.txt   7298907

Data Files

Seq Description Document Type Size
7 EX-101.SCH mrns-20240630.xsd EX-101.SCH 60007
8 EX-101.CAL mrns-20240630_cal.xml EX-101.CAL 52495
9 EX-101.DEF mrns-20240630_def.xml EX-101.DEF 185018
10 EX-101.LAB mrns-20240630_lab.xml EX-101.LAB 468095
11 EX-101.PRE mrns-20240630_pre.xml EX-101.PRE 325943
78 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20240630x10q_htm.xml XML 1132754
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 241198840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)